Home / Pfizer INC (PFE)
Sponsor pipeline · PFE

Pfizer INC

Forward clinical-stage catalysts linked to PFE

19
Tracked catalysts (sample)
15
Clinical-stage assets
2026-08-30
Nearest catalyst
elranatamab
READOUT · Phase 32026-08-30
mevrometostat
READOUT · Phase 32026-12-02
ritlecitinib higher
READOUT · Phase 32026-12-02
ritlecitinib lower
READOUT · Phase 32026-12-02
ritlecitinib
READOUT · Phase 32026-12-21
vepdegestrant
READOUT · Phase 32026-12-30
axitinib
READOUT · Phase 32026-12-31
disitamab vedotin
READOUT · Phase 32026-12-31
lorlatanib
READOUT · Phase 32026-12-31
talazoparib
READOUT · Phase 32026-12-31
utomilumab
READOUT · Phase 32026-12-31
tofacitinib
READOUT · Phase 32027-04-14
abrocitinib
READOUT · Phase 32027-05-02
binimetinib
READOUT · Phase 32027-06-30
encorafenib
READOUT · Phase 32027-06-30
!

Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.

This sponsor's catalysts are a slice of the free CSA sample. The full snapshot spans 139 listed sponsors and 2,103 forward catalysts.

Get the full dataset — $499 →